|

Carotuximab Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: ENV105, TRC105

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Karen Reckamp, MD, MS1
  • Edwin Posadas, MD1

Indications

  • Cancer2
  • Castration-resistant Prostate Cancer1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Beverly Hills, California1 trial

Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer

Cedars-Sinai Cancer at Beverly Hills (THO)

Phase 1

Duarte, California1 trial

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

City of Hope

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.